Skip to main content
Log in

Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases

  • Original Contributions
  • Published:
Ricerca in clinica e in laboratorio

Summary

Circulating immune complexes (CIC) were investigated by the fluid-phase Clq binding test in serum samples from 131 subjects with various clinical types of HBsAg-positive and HBsAg-negative chronic hepatitis diagnosed on both clinical and laboratory criteria, including liver biopsy; serum samples from 28 asymptomatic HBsAg carriers and 75 healthy controls were also examined. The results of these findings were correlated with the liver damage and the clinical course of the disease. CIC were detected in all categories of chronic hepatitis with a significant prevalence only in patients with liver cirrhosis. No correlation was found between the leveis of CIC, the presence of circulating HBsAg, and active inflammation or necrosis in any of the different types of chronic hepatitis. In contrast, a highly significant correlation was found between the prevalence of CIC and a more severe prognosis in patients with CAH and liver cirrhosis. The findings suggest that the presence of CIC is not specific for a given type of chronic liver disease and that they do not play any role in the pathogenesis of liver damage. The correlation observed between the presence of CIC and an unfavourable course of chronic liver disease suggests that CIC may modify the host’s immune defence mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abrass C. K., Border W. A., Hepner G.: Non-specificity of circulating immune complexes in patients with the acute and chronic liver disease. Clin. exp. Immunol.40, 292, 1980.

    PubMed  CAS  Google Scholar 

  2. Amlot P. L., Pussel B., Slaney J. M., Williams B. D.: Correlation between immune complexes and prognostic factors in Hodgkin’s disease. Clin. exp. Immunol.31, 166, 1978.

    PubMed  CAS  Google Scholar 

  3. Bratting N., Berg P. A.: Serum inhibitory factors (SIF) in patients with acute and chrome hepatitis and their clinical significance. Clin. exp. Immunol.25, 40, 1976.

    Google Scholar 

  4. Carpenter N. A., Louis J. A., Lambert P. H., Cerottini J. C.: Human cancer immunology In:Serroub B., Rosenfeld C. (Eds): Circulating immune complexes in human cancer North-Holland Publ., Amsterdam, 1980.

    Google Scholar 

  5. De Groote J., Desmet V. J., Gedik P., Korb G., Popper H., Poulsen H., Schmid M., Thaler H., Vehlinger E., Wepler W.: A classification of chronic hepatitis. Lancet11, 626, 1968.

    Google Scholar 

  6. Dienstag J. L., Bhan A. K., Alter H. J., Feinstone S. M., Purcell R. H.: Circulating immune complexes in non-A, non-B hepatitis. Lanceti, 1265, 1979.

    Article  Google Scholar 

  7. Dienstag J. L., Rhodes A. R., Bhan A. K., Dvorak A. M., Mihn M. C., Wands J. R.: Urticaria associated with acute viral hepatitis type B. Studies of pathogenesis. Ann. intern. Med.89, 34, 1978.

    PubMed  CAS  Google Scholar 

  8. Farivar M., Wands J. R., Benson G. D., Dienstag J. L., Isselbacher K. J.: Cryoprotein complexes and peripheral neuropathy in a patient with chronic active hepatitis. Gastroenterology71, 490, 1976.

    PubMed  CAS  Google Scholar 

  9. Gitnick G. L., Summerskill W. H. J., Soloway R. D., Ritman S.: Anticomplementary hepatitis B antigen. Prognostic importance in chronic active liver disease. Arch. intern. Med.132, 502, 1973.

    Article  PubMed  CAS  Google Scholar 

  10. Hopf U., Arnold W., Meyer zum Buschenfelde K. H., Forster E., Bolte J. P.: Studies on the pathogenesis of chronic inflammatory liver diseases. Membrane-fixed IgG on isolated hepatocytes from patients. Clin. exp. Immunol.22, 1, 1975.

    PubMed  CAS  Google Scholar 

  11. Kakumu S., Hotta R., Kashio T., Kuriki J.: Circulating immune complexes against suppressor T cell in chronic active liver disease. Gastroenterology79, 1111, 1980.

    Google Scholar 

  12. Kohler P. F., Cronin R. E., Hammond W. S., Olin D., Carr R. I.: Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann. intern. Med.81, 448, 1974.

    PubMed  CAS  Google Scholar 

  13. Mahieu P., Lambert P. H., Miescher P. A.: Detection of anti-glomerular membrane antibodies by a radioimmunological technique. Clinical application in human nephropathies. J. clin. Invest.54, 128, 1974.

    Article  PubMed  CAS  Google Scholar 

  14. Mozan C. J., Ryder G., Turk J. L., Waters M. F. R.: Evidence for circulating immune complexes in lepromatous leprosy. Lancetii, 572, 1972.

    Google Scholar 

  15. Nydegger U. E., Lambert P. H., Gerber H., Miescher P. A.: Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled Clq. J. clin. Invest.54, 297, 1974.

    Article  PubMed  CAS  Google Scholar 

  16. Oldstone M. B. A., Dixon F. J.: Immune complexes disease in chronic viral infection. J. exp. Med.134, 32, 1971.

    Google Scholar 

  17. Prince A. M., Trepo C.: Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. Lanceti, 1309, 1971.

    Article  Google Scholar 

  18. Schena F. P., Pastore G., Pastore A., Angarano G., Meliconi L., Schiraldi O., Bonomo L.: Characterization of the circulating immune complexes in acute and chronic liver disease. J. clin. Lab. Immunol.10, 179, 1983.

    PubMed  CAS  Google Scholar 

  19. Sodoman C. P., Prokein K., Schmidt H., Martini G. H.: Circulating immune complexes in liver disease. Z. Gastroent.16, 501, 1978.

    Google Scholar 

  20. Thomas H. C., MacSween R. N. M., White R. G.: The role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lanceti, 1288, 1973.

    Article  Google Scholar 

  21. Thomas H. C., Vaezaden F.: A homeostasis mechanism from the removal of antigen from portal circulation. Immunology26, 375, 1974.

    PubMed  CAS  Google Scholar 

  22. Trepo C., Vincent C., Vitvitski L., Berthoux F., Dupont J., Revillard J. P.: Detection of circulating immune complexes by the Clq-binding activity (Clq-BA) in liver disease with or without HBsAg. In:Peeters H. H. (Ed.): Protides of the biological fluids 26th Colloquium. Pergamon Press, Oxford-New York, 1978: p. 371.

    Google Scholar 

  23. Trepo C., Zuckerman A. J., Bird R. C., Prince A. M.: The role of circulating hepatitis B antigen/antibody immune complexes in pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J. clin. Path.27, 863, 1974.

    Article  PubMed  CAS  Google Scholar 

  24. Tricer D. R., Alp M. H., Krigt R.: Bacterial and dietary antibodies in liver disease. Lance.i, 60, 1972.

    Google Scholar 

  25. Wands J. R., Alpert E., Isselbacher K. J.: Arthritis-associated active hepatitis Complement activation and characterization of circulating immune complexes. Gastroenterology69, 1286, 1975.

    PubMed  CAS  Google Scholar 

  26. Zubler P. H., Miescher P. A.: Circulating and intra articular immune complexes inpatients with rheumatoid arthritis. J. clin. Invest.57, 1308, 1976.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by grants from theConsiglio Nazionale delle Ricerche (CNR) and from theMinistero della Pubblica Istruzione, Roma, Italy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pastore, G., Schena, F.P., Angarano, G. et al. Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases. La Ricerca Clin. Lab. 14, 29–35 (1984). https://doi.org/10.1007/BF02905037

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02905037

Key-words

Navigation